Literature DB >> 34039847

Severe bleeding in the ICU.

Marcel J Rauer1, Vanessa Neef2, Lorenzo Berra3.   

Abstract

PURPOSE OF REVIEW: Severe bleeding events, which require blood transfusions, are a challenge faced by many critical care physicians on a daily basis. Current transfusion guidelines generally recommend rather strict transfusion thresholds and strategies, which can appear opposing to a patient in need for urgent transfusion at first sight. Moreover, applied guidelines are lacking evidence and specificity for the typical ICU patient population and its comorbidities. Transfusion decisions, which are pivotal for clinical outcome, are often unsatisfactorily based on hemoglobin levels only. RECENT
FINDINGS: Recent publications generally support previous studies that a strict transfusion regimen is superior to a liberal one for the majority of cases. Newly developed and easily feasible techniques are currently in clinical trials and have the potential to become a valuable supplementation to hemoglobin-guided decision-making. In addition to the choice of the ideal transfusion strategy, physiological status and comorbidities were found to have a major impact on the outcome of severe bleedings in the ICU.
SUMMARY: The body of evidence for ICU-specific transfusion guidelines is scarce. Critical care physicians should properly evaluate their patient's comorbidities and consider extended point-of-care testing for transfusion decisions in indistinct anemic situations. A strict transfusion strategy should, however, be applied whenever possible.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34039847     DOI: 10.1097/ACO.0000000000001019

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  1 in total

1.  Preoperative anaemia and red blood cell transfusion in patients with aneurysmal subarachnoid and intracerebral haemorrhage - a multicentre subanalysis of the German PBM Network Registry.

Authors:  Elke Schmitt; Patrick Meybohm; Vanessa Neef; Peter Baumgarten; Alexandra Bayer; Suma Choorapoikayil; Patrick Friederich; Jens Friedrich; Christof Geisen; Erdem Güresir; Matthias Grünewald; Martin Gutjahr; Philipp Helmer; Eva Herrmann; Markus Müller; Diana Narita; Ansgar Raadts; Klaus Schwendner; Erhard Seifried; Patrick Stark; Andrea U Steinbicker; Josef Thoma; Markus Velten; Henry Weigt; Christoph Wiesenack; Maria Wittmann; Kai Zacharowski; Florian Piekarski
Journal:  Acta Neurochir (Wien)       Date:  2022-02-26       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.